{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:32:04Z","timestamp":1787671924513,"version":"build-2736575974"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00535-026-02458-6","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T03:10:14Z","timestamp":1781665814000},"page":"1295-1311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regulatory mechanism of the RNF168\u2013SCCA1\u2013MYH9 signaling axis in the response of ulcerative colitis"],"prefix":"10.1007","volume":"61","author":[{"given":"Xuanqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-3096","authenticated-orcid":false,"given":"Yingying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2458_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-pathol-012615-044152","volume":"11","author":"TC Liu","year":"2016","unstructured":"Liu TC, Stappenbeck TS. Genetics and Pathogenesis of Inflammatory Bowel Disease. Annu Rev Pathol. 2016;11:127\u201348.","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"2458_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"DJ Klionsky","year":"2012","unstructured":"Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012;8(4):445\u2013544.","journal-title":"Autophagy"},{"issue":"10432","key":"2458_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet. 2024;403(10432):1177\u201391.","journal-title":"Lancet"},{"issue":"10401","key":"2458_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402(10401):571\u201384.","journal-title":"Lancet"},{"issue":"10","key":"2458_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.tips.2024.08.003","volume":"45","author":"P Wangchuk","year":"2024","unstructured":"Wangchuk P, Yeshi K, Loukas A. Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments. Trends Pharmacol Sci. 2024;45(10):892\u2013903.","journal-title":"Trends Pharmacol Sci"},{"issue":"12","key":"2458_CR6","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1136\/gut.2006.107953","volume":"55","author":"R Sanchez","year":"2006","unstructured":"Sanchez R, et al. Paraoxonase 1, 2 and 3 DNA variants and susceptibility to childhood inflammatory bowel disease. Gut. 2006;55(12):1820\u20131.","journal-title":"Gut"},{"issue":"1","key":"2458_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12937-019-0492-9","volume":"18","author":"P Mirmiran","year":"2019","unstructured":"Mirmiran P, et al. Does the inflammatory potential of diet affect disease activity in patients with inflammatory bowel disease? Nutr J. 2019;18(1):65.","journal-title":"Nutr J"},{"issue":"6","key":"2458_CR8","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","volume":"126","author":"EV Loftus Jr","year":"2004","unstructured":"Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126(6):1504\u201317.","journal-title":"Gastroenterology"},{"issue":"3","key":"2458_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000228554","volume":"27","author":"C Fiocchi","year":"2009","unstructured":"Fiocchi C. Susceptibility genes and overall pathogenesis of inflammatory bowel disease: where do we stand? Dig Dis. 2009;27(3):226\u201335.","journal-title":"Dig Dis"},{"issue":"1","key":"2458_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrm.2017.83","volume":"19","author":"M Rape","year":"2018","unstructured":"Rape M. Ubiquitylation at the crossroads of development and disease. Nat Rev Mol Cell Biol. 2018;19(1):59\u201370.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2458_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X. Post-Translational Modification Control of Innate Immunity. Immunity. 2016;45(1):15\u201330.","journal-title":"Immunity"},{"issue":"9","key":"2458_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003723","volume":"9","author":"M Beaudoin","year":"2013","unstructured":"Beaudoin M, et al. Deep resequencing of GWAS loci identifies rare variants in CARD9, IL23R and RNF186 that are associated with ulcerative colitis. PLoS Genet. 2013;9(9):e1003723.","journal-title":"PLoS Genet"},{"issue":"6","key":"2458_CR13","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/ibd\/izy085","volume":"24","author":"W Turpin","year":"2018","unstructured":"Turpin W, et al. Determinants of IBD Heritability: Genes, Bugs, and More. Inflamm Bowel Dis. 2018;24(6):1133\u201348.","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"2458_CR14","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gutjnl-2012-303205","volume":"63","author":"I Cleynen","year":"2014","unstructured":"Cleynen I, et al. Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut. 2014;63(8):1265\u201374.","journal-title":"Gut"},{"issue":"23","key":"2458_CR15","doi-asserted-by":"publisher","first-page":"13465","DOI":"10.1073\/pnas.95.23.13465","volume":"95","author":"C Schick","year":"1998","unstructured":"Schick C, et al. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition. Proc Natl Acad Sci U S A. 1998;95(23):13465\u201370.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2458_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.cell.2016.03.003","volume":"165","author":"FE Morreale","year":"2016","unstructured":"Morreale FE, Walden H. Types of Ubiquitin Ligases. Cell. 2016;165(1):248-248.e1.","journal-title":"Cell"},{"issue":"3","key":"2458_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/cells10030561","volume":"10","author":"F Marzano","year":"2021","unstructured":"Marzano F, et al. Emerging Roles of TRIM8 in Health and Disease. Cells. 2021;10(3):561.","journal-title":"Cells"},{"issue":"4","key":"2458_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nsmb.2780","volume":"21","author":"CE Berndsen","year":"2014","unstructured":"Berndsen CE, Wolberger C. New insights into ubiquitin E3 ligase mechanism. Nat Struct Mol Biol. 2014;21(4):301\u20137.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"2458_CR19","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.celrep.2016.01.020","volume":"14","author":"O Tarcic","year":"2016","unstructured":"Tarcic O, et al. RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated Cancer. Cell Rep. 2016;14(6):1462\u201376.","journal-title":"Cell Rep"},{"issue":"3","key":"2458_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/ecco-jcc\/jjy165","volume":"13","author":"RL Kosinsky","year":"2019","unstructured":"Kosinsky RL, et al. Loss of RNF40 Decreases NF-\u03baB Activity in Colorectal Cancer Cells and Reduces Colitis Burden in Mice. J Crohns Colitis. 2019;13(3):362\u201373.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"2458_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/ecco-jcc\/jjw023","volume":"10","author":"Q Yu","year":"2016","unstructured":"Yu Q, et al. E3 Ubiquitin ligase RNF183 Is a Novel Regulator in Inflammatory Bowel Disease. J Crohns Colitis. 2016;10(6):713\u201325.","journal-title":"J Crohns Colitis"},{"issue":"2","key":"2458_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/mi.2016.58","volume":"10","author":"K Fujimoto","year":"2017","unstructured":"Fujimoto K, et al. Regulation of intestinal homeostasis by the ulcerative colitis-associated gene RNF186. Mucosal Immunol. 2017;10(2):446\u201359.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2458_CR23","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/s41467-020-16307-4","volume":"11","author":"JL Kelliher","year":"2020","unstructured":"Kelliher JL, et al. Histone H2A variants alpha1-extension helix directs RNF168-mediated ubiquitination. Nat Commun. 2020;11(1):2462.","journal-title":"Nat Commun"},{"issue":"9","key":"2458_CR24","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/febs.15857","volume":"289","author":"J Kelliher","year":"2022","unstructured":"Kelliher J, Ghosal G, Leung JWC. New answers to the old RIDDLE: RNF168 and the DNA damage response pathway. Febs j. 2022;289(9):2467\u201380.","journal-title":"Febs j"},{"issue":"Suppl 1","key":"2458_CR25","doi-asserted-by":"publisher","first-page":"i33","DOI":"10.1093\/jrr\/rrw027","volume":"57","author":"S Nakada","year":"2016","unstructured":"Nakada S. Opposing roles of RNF8\/RNF168 and deubiquitinating enzymes in ubiquitination-dependent DNA double-strand break response signaling and DNA-repair pathway choice. J Radiat Res. 2016;57(Suppl 1):i33\u201340.","journal-title":"J Radiat Res"},{"issue":"3","key":"2458_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/molecules28031417","volume":"28","author":"T Xie","year":"2023","unstructured":"Xie T, et al. Emerging Roles of RNF168 in Tumor Progression. Molecules. 2023;28(3):1417.","journal-title":"Molecules"},{"issue":"46","key":"2458_CR27","doi-asserted-by":"publisher","first-page":"45296","DOI":"10.1074\/jbc.M307741200","volume":"278","author":"K Masumoto","year":"2003","unstructured":"Masumoto K, et al. Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. J Biol Chem. 2003;278(46):45296\u2013304.","journal-title":"J Biol Chem"},{"issue":"2","key":"2458_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/gyno.1994.1272","volume":"55","author":"JA Bolli","year":"1994","unstructured":"Bolli JA, et al. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix. Gynecol Oncol. 1994;55(2):169\u201373.","journal-title":"Gynecol Oncol"},{"issue":"6","key":"2458_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000030045","volume":"19","author":"GC Torre","year":"1998","unstructured":"Torre GC. SCC antigen in malignant and nonmalignant squamous lesions. Tumour Biol. 1998;19(6):517\u201326.","journal-title":"Tumour Biol"},{"issue":"21","key":"2458_CR30","doi-asserted-by":"publisher","first-page":"6318","DOI":"10.1158\/0008-5472.CAN-14-0798","volume":"74","author":"N Sheshadri","year":"2014","unstructured":"Sheshadri N, et al. SCCA1\/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling. Cancer Res. 2014;74(21):6318\u201329.","journal-title":"Cancer Res"},{"key":"2458_CR31","doi-asserted-by":"publisher","first-page":"3729","DOI":"10.1038\/ncomms4729","volume":"5","author":"JM Catanzaro","year":"2014","unstructured":"Catanzaro JM, et al. Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3\/B4. Nat Commun. 2014;5:3729.","journal-title":"Nat Commun"},{"issue":"7","key":"2458_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/labinvest.2010.55","volume":"90","author":"C Turato","year":"2010","unstructured":"Turato C, et al. SERPINB3 modulates TGF-beta expression in chronic liver disease. Lab Invest. 2010;90(7):1016\u201323.","journal-title":"Lab Invest"},{"key":"2458_CR33","doi-asserted-by":"publisher","DOI":"10.1590\/1678-7757-2021-0374","volume":"29","author":"S Derakhshan","year":"2021","unstructured":"Derakhshan S, et al. Evaluation of squamous cell carcinoma antigen 1 expression in oral squamous cell carcinoma (tumor cells and peritumoral T-lymphocytes) and verrucous carcinoma and comparison with normal oral mucosa. J Appl Oral Sci. 2021;29:e20210374.","journal-title":"J Appl Oral Sci"},{"issue":"15","key":"2458_CR34","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163841","volume":"133","author":"L Chen","year":"2023","unstructured":"Chen L, et al. SCCA1\/SERPINB3 suppresses antitumor immunity and blunts therapy-induced T cell responses via STAT-dependent chemokine production. J Clin Invest. 2023;133(15):e163841.","journal-title":"J Clin Invest"},{"issue":"4","key":"2458_CR35","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.18632\/oncotarget.2943","volume":"6","author":"S Cannito","year":"2015","unstructured":"Cannito S, et al. Hypoxia up-regulates SERPINB3 through HIF-2alpha in human liver cancer cells. Oncotarget. 2015;6(4):2206\u201321.","journal-title":"Oncotarget"},{"issue":"12","key":"2458_CR36","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/cancers11121933","volume":"11","author":"S Cannito","year":"2019","unstructured":"Cannito S, et al. SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1alpha and -2alpha in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets. Cancers (Basel). 2019;11(12):1933.","journal-title":"Cancers (Basel)"},{"key":"2458_CR37","doi-asserted-by":"publisher","first-page":"7166","DOI":"10.1038\/ncomms8166","volume":"6","author":"B Zhao","year":"2015","unstructured":"Zhao B, et al. The non-muscle-myosin-II heavy chain Myh9 mediates colitis-induced epithelium injury by restricting Lgr5+ stem cells. Nat Commun. 2015;6:7166.","journal-title":"Nat Commun"},{"issue":"5","key":"2458_CR38","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.stemcr.2021.03.027","volume":"16","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Non-muscle myosin heavy chain 9 maintains intestinal homeostasis by preventing epithelium necroptosis and colitis adenoma formation. Stem Cell Reports. 2021;16(5):1290\u2013301.","journal-title":"Stem Cell Reports"},{"issue":"7770","key":"2458_CR39","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41586-019-1450-6","volume":"572","author":"MD Wellenstein","year":"2019","unstructured":"Wellenstein MD, et al. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis. Nature. 2019;572(7770):538\u201342.","journal-title":"Nature"},{"issue":"6168","key":"2458_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.1248627","volume":"343","author":"D Schramek","year":"2014","unstructured":"Schramek D, et al. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. Science. 2014;343(6168):309\u201313.","journal-title":"Science"},{"key":"2458_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116118","volume":"171","author":"Q Liu","year":"2024","unstructured":"Liu Q, et al. MYH9: A key protein involved in tumor progression and virus-related diseases. Biomed Pharmacother. 2024;171:116118.","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"2458_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202203573","volume":"10","author":"Q Li","year":"2023","unstructured":"Li Q, et al. SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3\u03b2\/\u03b2-Catenin Signaling. Adv Sci (Weinh). 2023;10(11):e2203573.","journal-title":"Adv Sci (Weinh)"},{"key":"2458_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cyto.2018.10.020","volume":"113","author":"N Barabutis","year":"2019","unstructured":"Barabutis N, Uddin MA, Catravas JD. Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation. Cytokine. 2019;113:427\u201332.","journal-title":"Cytokine"},{"issue":"11","key":"2458_CR44","doi-asserted-by":"publisher","first-page":"a026161","DOI":"10.1101\/cshperspect.a026161","volume":"6","author":"AV Gudkov","year":"2016","unstructured":"Gudkov AV, Komarova EA. p53 and the Carcinogenicity of Chronic Inflammation. Cold Spring Harb Perspect Med. 2016;6(11):a026161.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2458_CR45","doi-asserted-by":"publisher","first-page":"101889","DOI":"10.1016\/j.molmet.2024.101889","volume":"81","author":"G Villano","year":"2024","unstructured":"Villano G, et al. The protease activated receptor 2 - CCAAT\/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis. Mol Metab. 2024;81:101889.","journal-title":"Mol Metab"},{"key":"2458_CR46","unstructured":"Katagiri, C., et al., SCCA-1 PRODUCTION INHIBITOR HAVING 1-PIPERIDINEPROPIONIC ACID AND\/OR ITS SALT AS ACTIVE INGREDIENT. 2008, SHISEIDO CO LTD."},{"key":"2458_CR47","unstructured":"Pontisso, P., et al., 1-piperidinepropionic acid for treating a fibrosing disease. 2023, Google Patents."},{"key":"2458_CR48","unstructured":"Pontisso, P., et al., The serpinb3 inhibitor piperidinpropionic acid for tumor treatment. 2022, Google Patents."},{"issue":"4","key":"2458_CR49","first-page":"706","volume":"42","author":"MD Yu Xia","year":"2026","unstructured":"Yu Xia MD, Jinkui WU, Mengbin LI. Research progress on the regulatory mechanism of MYH9 in intestinal epithelial cells and related diseases. J Pract Med. 2026;42(4):706\u201313.","journal-title":"J Pract Med"},{"issue":"11","key":"2458_CR50","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20(11):1242\u201353.","journal-title":"Nat Med"},{"issue":"18","key":"2458_CR51","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.1073\/pnas.0611551104","volume":"104","author":"K Arimoto","year":"2007","unstructured":"Arimoto K, et al. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci U S A. 2007;104(18):7500\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2458_CR52","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/ni1110","volume":"5","author":"DL Boone","year":"2004","unstructured":"Boone DL, et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004;5(10):1052\u201360.","journal-title":"Nat Immunol"},{"issue":"7578","key":"2458_CR53","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15401","volume":"527","author":"T Thorslund","year":"2015","unstructured":"Thorslund T, et al. Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage. Nature. 2015;527(7578):389\u201393.","journal-title":"Nature"},{"issue":"5","key":"2458_CR54","doi-asserted-by":"publisher","first-page":"265","DOI":"10.5483\/BMBRep.2023-0037","volume":"56","author":"EH Jo","year":"2023","unstructured":"Jo EH, et al. Ubiquitin E3 ligases in cancer: somatic mutation and amplification. BMB Rep. 2023;56(5):265\u201374.","journal-title":"BMB Rep"},{"issue":"7","key":"2458_CR55","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1515\/CCLM.2003.130","volume":"41","author":"K Izuhara","year":"2003","unstructured":"Izuhara K. The role of interleukin-4 and interleukin-13 in the non-immunologic aspects of asthma pathogenesis. Clin Chem Lab Med. 2003;41(7):860\u20134.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2458_CR56","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I","volume":"40","author":"H Kato","year":"1977","unstructured":"Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer. 1977;40(4):1621\u20138.","journal-title":"Cancer"},{"issue":"1","key":"2458_CR57","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/002215540004800112","volume":"48","author":"S Cataltepe","year":"2000","unstructured":"Cataltepe S, et al. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem. 2000;48(1):113\u201322.","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"2458_CR58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/1097-0215(20010120)95:1<39::AID-IJC1007>3.0.CO;2-N","volume":"95","author":"J Stenman","year":"2001","unstructured":"Stenman J, et al. Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck. Int J Cancer. 2001;95(1):39\u201343.","journal-title":"Int J Cancer"},{"issue":"1","key":"2458_CR59","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s42003-021-02893-6","volume":"5","author":"S Wang","year":"2022","unstructured":"Wang S, et al. SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation. Commun Biol. 2022;5(1):46.","journal-title":"Commun Biol"},{"issue":"10","key":"2458_CR60","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1073\/pnas.0600040103","volume":"103","author":"CS Collins","year":"2006","unstructured":"Collins CS, et al. A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase. Proc Natl Acad Sci U S A. 2006;103(10):3775\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2458_CR61","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.3390\/ph16101486","volume":"16","author":"M Chinellato","year":"2023","unstructured":"Chinellato M, et al. 1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2. Pharmaceuticals (Basel). 2023;16(10):1486.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"2458_CR62","first-page":"202","volume":"19","author":"C Turato","year":"2015","unstructured":"Turato C, Pontisso P. SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3). Atlas Genet Cytogenet Oncol Haematol. 2015;19(3):202\u20139.","journal-title":"Atlas Genet Cytogenet Oncol Haematol"},{"key":"2458_CR63","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.semcdb.2016.09.005","volume":"62","author":"Y Sun","year":"2017","unstructured":"Sun Y, Sheshadri N, Zong WX. SERPINB3 and B4: From biochemistry to biology. Semin Cell Dev Biol. 2017;62:170\u20137.","journal-title":"Semin Cell Dev Biol"},{"issue":"3\u20134","key":"2458_CR64","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000488672","volume":"234","author":"Z Sun","year":"2018","unstructured":"Sun Z, et al. Serum Squamous Cell Carcinoma Antigen in Psoriasis: A Potential Quantitative Biomarker for Disease Severity. Dermatology. 2018;234(3\u20134):120\u20136.","journal-title":"Dermatology"},{"issue":"6806","key":"2458_CR65","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/35038119","volume":"407","author":"JA Huntington","year":"2000","unstructured":"Huntington JA, Read RJ, Carrell RW. Structure of a serpin-protease complex shows inhibition by deformation. Nature. 2000;407(6806):923\u20136.","journal-title":"Nature"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02458-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02458-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02458-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:07:46Z","timestamp":1787670466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02458-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":65,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2458"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02458-6","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal work was performed in compliance with relevant guidelines by the Ethical Committee of China Pharmaceutical University (Ethical number 2025\u201302-032).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}